Literature DB >> 20056903

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Charlene D Fell1, Fernando J Martinez, Lyrica X Liu, Susan Murray, Meilan K Han, Ella A Kazerooni, Barry H Gross, Jeffrey Myers, William D Travis, Thomas V Colby, Galen B Toews, Kevin R Flaherty.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis (IPF) and other idiopathic interstitial pneumonias (IIPs) have similar clinical and radiographic features, but their histopathology, response to therapy, and natural history differ. A surgical lung biopsy is often required to distinguish between these entities.
OBJECTIVES: We sought to determine if clinical variables could predict a histopathologic diagnosis of IPF in patients without honeycomb change on high-resolution computed tomography (HRCT).
METHODS: Data from 97 patients with biopsy-proven IPF and 38 patients with other IIPs were examined. Logistic regression models were built to identify the clinical variables that predict histopathologic diagnosis of IPF.
MEASUREMENTS AND MAIN RESULTS: Increasing age and average total HRCT interstitial score on HRCT scan of the chest may predict a biopsy confirmation of IPF. Sex, pulmonary function, presence of desaturation, or distance walked during a 6-minute walk test did not help discriminate pulmonary fibrosis from other IIPs.
CONCLUSIONS: Clinical data may be used to predict a diagnosis of IPF over other IIPs. Validation of these data with a prospective study is needed.

Entities:  

Mesh:

Year:  2010        PMID: 20056903      PMCID: PMC2854332          DOI: 10.1164/rccm.200906-0959OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Idiopathic pulmonary fibrosis: a disorder of lung regeneration?

Authors:  Victor J Thannickal; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2008-10-01       Impact factor: 21.405

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

Review 4.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

5.  Outcomes and safety of surgical lung biopsy for interstitial lung disease.

Authors:  Christopher J Lettieri; Ganesh R Veerappan; Donald L Helman; Charles R Mulligan; Andrew F Shorr
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 7.  Idiopathic interstitial pneumonias: CT features.

Authors:  David A Lynch; William D Travis; Nestor L Müller; Jeffrey R Galvin; David M Hansell; Philippe A Grenier; Talmadge E King
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

8.  Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

Authors:  Yangjin Jegal; Dong Soon Kim; Tae Sun Shim; Chae-Man Lim; Sang Do Lee; Younsuck Koh; Woo Sung Kim; Won Dong Kim; Jin Seong Lee; William D Travis; Masanori Kitaichi; Thomas V Colby
Journal:  Am J Respir Crit Care Med       Date:  2005-01-07       Impact factor: 21.405

9.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

Authors:  Kevin R Flaherty; Talmadge E King; Ganesh Raghu; Joseph P Lynch; Thomas V Colby; William D Travis; Barry H Gross; Ella A Kazerooni; Galen B Toews; Qi Long; Susan Murray; Vibha N Lama; Steven E Gay; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

10.  BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.

Authors:  S Veeraraghavan; P I Latsi; A U Wells; P Pantelidis; A G Nicholson; T V Colby; P L Haslam; E A Renzoni; R M du Bois
Journal:  Eur Respir J       Date:  2003-08       Impact factor: 16.671

View more
  66 in total

1.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

2.  The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Authors:  Robert Brownell; Teng Moua; Travis S Henry; Brett M Elicker; Darin White; Eric Vittinghoff; Kirk D Jones; Anatoly Urisman; Carlos Aravena; Kerri A Johannson; Jeffrey A Golden; Talmadge E King; Paul J Wolters; Harold R Collard; Brett Ley
Journal:  Thorax       Date:  2017-01-12       Impact factor: 9.139

3.  Body mass index-percent forced vital capacity-respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients.

Authors:  Tomoo Kishaba; Hiroaki Nagano; Yuichiro Nei; Shin Yamashiro
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 4.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.

Authors:  Wen-Tan Huang; Hasina Akhter; Chunsun Jiang; Mark MacEwen; Qiang Ding; Veena Antony; Victor John Thannickal; Rui-Ming Liu
Journal:  Exp Gerontol       Date:  2014-11-28       Impact factor: 4.032

Review 6.  Air pollution exposure: a novel environmental risk factor for interstitial lung disease?

Authors:  Kerri A Johannson; John R Balmes; Harold R Collard
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

7.  Relative binding affinities of integrin antagonists by equilibrium dialysis and liquid chromatography-mass spectrometry.

Authors:  William J Tipping; Nkazimulo Tshuma; James Adams; Harvey T Haywood; James E Rowedder; M Jonathan Fray; Thomas McInally; Simon J F Macdonald; Neil J Oldham
Journal:  ACS Med Chem Lett       Date:  2014-12-22       Impact factor: 4.345

8.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

9.  What Is in a Pattern? That Which We Call Idiopathic Pulmonary Fibrosis by Any Other Pattern Would Behave Alike!

Authors:  Joao A de Andrade; Tracy Luckhardt
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

10.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Authors:  Margaret L Salisbury; Meng Xia; Susan Murray; Brian J Bartholmai; Ella A Kazerooni; Catherine A Meldrum; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-07-28       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.